[ad_1]
For stocks, see Golden Unicorn’s Authorized, Professional, Timely, and Comprehensive Analyst Research Report to help you seize potential thematic opportunities.
The epidemic stimulates short-term demand for cold chain logistics, some experts say the new corona vaccine has limited demand for cold chain equipment.
Source: The Voice of Securities Daily
Daily Values
Due to the uniqueness of vaccine products, the delivery process requires a complete cold chain As the launch of the new corona vaccine approaches, the concept of cold chain transportation has started to attract the attention of the market. In particular, the new corona vaccine developed by the German biotechnology company BioNTech requires a storage condition of -70 ° C, prompting a rush to buy cold chain transport facilities abroad.
The new corona vaccine may stimulate demand from the cold chain logistics market, but a Securities Daily reporter found that, although market demand in the cold chain transportation industry has increased year over year, Demand for the new corona vaccine has not skyrocketed in advance due to the imminent launch of the new corona vaccine.
Short-term demand for cold chain transport equipment increases
According to data from the Cold Chain Committee of the China Federation of Things, in 2019, the total amount of cold storage in the country was around 60.53 million tons, with 8.145 million tons of new storage capacity. . Among them, the number of reefer trucks in China has basically maintained a growth rate of more than 20% from 2015 to 2019. In the first half of 2020, due to the strong demand for cold chain logistics since the epidemic, the Demand for refrigerated trucks in China has increased by more than 80% year-on-year since April.
The market demand for cold chain logistics and transportation is not only reflected in the biological cold chain where the vaccine is located, but also in the fresh cold chain for further market growth. In April 2020, in the face of rapidly growing demand for China’s cold chain logistics, the Ministry of Agriculture and Rural Affairs issued theAgricultural productsThe “Implementing Opinions on the Construction of Cold Chain Facilities for Storage and Preservation of Fresh Produce”, proposed specific support measures to accelerate the construction of cold chain facilities for the storage and preservation of agricultural products, and also brought a favorable regulatory environment for the development of China’s cold chain logistics industry.
Currently, the compliant cold chain transportation industry has a high threshold. In the past, modified non-standard reefer container vehicles had hidden safety hazards, unprofessionalism, and poor transportation efficiency. Therefore, the standardized refrigerated vehicles that satisfy the long-distance fresh cold chain transport market are still There is a large gap.
Under the superposition of the stimulus of aggregate demand and the new concept of the corona vaccine, the capital market has responded positively and the inventories of the cold chain transport concept have recently increased.Chinese medicineChen Hongyan, general secretary of the Medical Devices Branch of the Materials Association, said in an interview with a Securities Daily reporter that although market demand for cold chain transport and logistics equipment continues to increase, its fields of application have not expanded significantly. Will the short-term increase in demand caused by the epidemic continue? to be observed.
New Crown vaccine has limited demand for cold chain equipment
Chen Hongyan said that vaccines are only one demand segment of the cold chain transportation market, and its own demand is small, and there are already a large number of related service companies, making it difficult to become a flash point in the cold chain logistics industry. Companies that provide cold chain transport services, such as medicines and vaccines, must obtain special qualifications and have certain licensing threshold restrictions.Currently, the production capacity of national companies that provide such cold chain services has not yet is saturated.
Chen Hongyan said: “In the future, even if there is demand for new cold chain equipment after the new corona vaccine is included, it will mainly be a new company that has not previously obtained the chain transport qualification. cold and is ready to participate in the cold chain transport service of the new corona vaccine. “
Tao Lina, a former vaccine expert at the Shanghai Centers for Disease Control and Prevention, told the Securities Daily reporter that the existing vaccine’s cold chain is primarily designed at 2-8 ° C. If the new one Corona vaccine developed by BioNTech must use professional ultra-low temperature equipment at -70 ° C Storage and transportation, once other vaccines that do not require ultra-low temperature storage are on the market, it will have an impact on the market coverage of such vaccines.
Currently, there are three routes for vaccines in China’s phase III clinical trials, including inactivated vaccines, adenovirus vector vaccines, and recombinant protein vaccines. All three vaccines only require storage conditions of 2 to 8 ° C. The existing vaccine cold chain Can meet transportation and storage needs.
Recently, BioNTech’s overseas partner Pfizer stated that it is developing a lyophilized formulation, which is expected to maintain the stability of the new corona vaccine under normal refrigeration, but is not expected to be available until 2022.
BioNTech’s domestic partners areFosun PharmaWu Yifang, president of Fosun Pharma, told a Securities Daily reporter that Fosun Pharma has some cold chain storage equipment, so the relevant input costs are not high and a -70 cold storage has been built ℃ near the airport. Once the vaccines are imported from abroad and into China, they will be stored in cold rooms for the first time, and Sinopharm will take care of the cold chain transportation, ensuring they are shipped to vaccination points across the country to – 70 ° C.
Vaccination sites have also maintained a steady demand for cold storage equipment. A reporter from the Securities Daily visited health centers in Beijing Tianqiao, Niujie and other places where influenza vaccines were vaccinated. The staff commented that although they had not received a notification, they would become new corona vaccination sites, but the hospital’s refrigeration equipment is fully equipped, and many refrigeration equipment has been set up recently in recent years.
The “Securities Daily” reporter visited and learned that national community health centers with vaccination ratings are often equipped with medical grade cryogenic refrigerators. Even if the new corona vaccine requires ultra-low temperature storage, it will not constitute a storage barrier.
Sina Statement: Sina.com publishes this article for the purpose of conveying more information and does not mean that I agree with their views or confirm their description. The content of the article is for reference only and does not constitute investment advice. Investors operate accordingly at their own risk.
Disclaimer: The content provided by Wemedia is derived from Wemedia and the copyright belongs to the original author. To reprint, contact the original author and obtain permission. Opinions in the article represent the author only, not Sina’s position. If the content involves investment advice, it is for reference only and should not be used as an investment basis. Investing is risky, so be careful when entering the market.
Massive information, accurate interpretation, all in the Sina Finance APP
Editor in charge: Chen Zhijie
